Form Type: 4

SEC EDGAR Link
Accession Number:0000899243-19-017005
Date:2019-06-13
Issuer: INFINITY PHARMACEUTICALS, INC. (INFI)
Original Submission Date:

Reporting Person:

SELBY NORMAN C
C/O INFINITY PHARMACEUTICALS, INC.
784 MEMORIAL DRIVE CAMBRIDGE, MA 02139

Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
Title of SecurityTransaction Date2a. Deemed Execution Date Transaction CodeSharesAcquired or DisposedPrice per share 5. Amount of Securities Beneficially Owned Following Reported Transaction 6. Ownership Form Direct or IndirectNature of Indirect Ownership
Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, convertible securities
Title of Derivative Security Conversion or Exercise Price of Derivative Security Transaction Date Deemed Execution Date Transaction Code Number of Derivative Securities Acquired (A) or Disposed of (D) Date ExercisableExpiration Date Title and Amount of Securities Underlying Derivative Security Price of Derivative Security Number of derivative Securities Beneficially Owned Following Reported Transaction(s) Ownership Form: Direct (D) or Indirect (I) Nature of Indirect Beneficial Ownership
STOCK OPTION (RIGHT TO BUY) 1.6 2019-06-13 deemed execution date A 30,000 (a) 2029-06-12 common stock 30,000 $1.60 0 direct
STOCK OPTION (RIGHT TO BUY) 1.6 2019-06-13 deemed execution date A 10,000 (a) 2029-06-12 common stock 10,000 $1.60 0 direct
Footnotes
IDfootnote
f1 the option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as a director of the issuer.
f2 the option vests over a period of one year in equal quarterly installments beginning at the end of the first quarter after the date of grant, provided that the holder continues to serve as lead independent director of the issuer's board of directors.
WhaleWisdom Logo

Elevate your investments